Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.95
Sabra Health Care REIT, Inc. incurred term loan of $500.0 million U.S. dollar term loan with KeyBank National Association as Administrative Agent and the lenders at ratings-based applicable interest margin plus, at the Operating Partnership’s op maturing July 30, 2030.
- Instrument
- term loan
- Principal
- $500.0 million U.S. dollar term loan
- Counterparty
- KeyBank National Association as Administrative Agent and the lenders
- Rate
- ratings-based applicable interest margin plus, at the Operating Partnership’s op
- Maturity
- July 30, 2030
- Event
- incurrence
Exact text from the filing
The Term Loan Credit Agreement includes a $500.0 million U.S. dollar term loan (the “Term Loan”). The Term Loan Credit Agreement also contains an accordion feature that can increase the total available borrowings to $1.0 billion, subject to terms and conditions. The Term Loan has a maturity date of July 30, 2030. The Term Loan bears interest on the outstanding principal amount at a ratings-based applicable interest margin plus, at the Operating Partnership’s option, either (a) Daily SOFR, (b) Term SOFR or (c) the Base Rate, each as defined in the Term Loan Credit Agreement. The ratings-based applicable interest margin for borrowings will vary based on the Debt Ratings, as defined in the Term Loan Credit Agreement, and will range from 0.800% to 1.600% per annum for SOFR-based borrowings and 0.000% to 0.600% per annum for borrowings at the Base Rate.
View on SEC.gov